Status:

COMPLETED

Reliability and Validity of the Turkish Version of SMİLE-C

Lead Sponsor:

Marmara University

Conditions:

Covid19

Eligibility:

All Genders

18-65 years

Brief Summary

How the life style changed multidimensionally with home isolation in the period of COVID-19 is a new research question. Physical and social isolation, home isolation, and quarantine policies applied d...

Eligibility Criteria

Inclusion

  • Female and male participants aged 18-65, Volunteering to participate in research

Exclusion

  • Inability to use a computer, tablet or mobile phone, Not answering all the questions in questionnaire

Key Trial Info

Start Date :

April 30 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 20 2022

Estimated Enrollment :

166 Patients enrolled

Trial Details

Trial ID

NCT04894279

Start Date

April 30 2021

End Date

February 20 2022

Last Update

March 11 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Berivan Beril KILIÇ

Istanbul, Turkey (Türkiye)

Reliability and Validity of the Turkish Version of SMİLE-C | DecenTrialz